Search For "jubilant life sciences"
Jubilant Life Sciences Q1 PAT down 52 pc at Rs 88 crore
Updated : 5 years, 6 months ago IST
Noida (Uttar Pradesh) [India], September 4 (ANI): Jubilant Life Sciences on Friday reported 52 per cent fall in its profit after tax of Rs 88 crore in the April to June quarter as against Rs 185 crore in the corresponding period of previous fiscal year.
Read More
Jubilant launches Remdesivir in India for treatment of COVID-19
Updated : 5 years, 7 months ago IST
Noida (Uttar Pradesh) [India], Aug 4 (ANI): Jubilant Life Sciences has launched Remdesivir for injection under the brand name JUBI-R in Indian market at a price of Rs 4,700 per vial of 100 mg and said it will make the drug available to over 1,000 hospitals providing COVID-19 treatment throug
Read More
COVID-19: DCGI nod to Jubilant Generics to manufacture, sell remdesivir f
Updated : 5 years, 7 months ago IST
New Delhi [India], July 20 (ANI): The Drug Controller General of India (DCGI) has granted permission to pharma giant- Jubilant Generics Ltd to manufacture and market the anti-viral drug remdesivir for "restricted emergency use" on hospitalised COVID-19 patients, a senior health ministry offi
Read More
COVID-19: Pharma giants seek DCGI's approval to manufacture, sell Remdesiv
Updated : 5 years, 9 months ago IST
New Delhi [India], June 4 (ANI): Two domestic pharmaceutical firms--Mylan and Jubilant Life Sciences have approached the country's top drug regulator--Drug Controller General of India (DCGI) to seek its approval to manufacture and sell anti-viral drug 'Remdesivir' in India to combat COVID-19
Read More
Jubilant Life Sciences surges 5 pc after signing deal with Gilead for prod
Updated : 5 years, 10 months ago IST
Mumbai (Maharashtra) [India], May 13 (ANI): The share price of Jubilant Life Sciences surged 5 per cent hitting upper circuit of Rs 429.95 per share on Wednesday after the company signed a deal with US-based Gilead Sciences Inc for production of Remdesivir to fight COVID-19.
Read More
Jubilant Life Sciences Q1 profit down 9 pc y-o-y to Rs 185 crore
Updated : 6 years, 7 months ago IST
Noida (Uttar Pradesh) [India], July 26 (ANI): Jubilant Life Sciences said on Friday its profit after tax edged 9 per cent lower at Rs 185 crore in the year-ago period.
Read More
Jubilant Life Sciences revenue up 21 pc to Rs 9,111 crore in FY 19
Updated : 6 years, 10 months ago IST
Noida (Uttar Pradesh) [India], May 17 (ANI): Jubilant Life Sciences said on Friday its consolidated revenue moved up 21 per cent to Rs 9,111 crore in fiscal 2018-19 year-on-year.
Read More
Jubilant Life Sciences to address USFDA concerns after warning
Updated : 7 years ago IST
Noida (Uttar Pradesh) [India], Mar 8 (ANI): Jubilant Life Sciences said on Friday that the US Food and Drug Administration (USFDA) has issued a warning letter after conducting an inspection at its manufacturing facility in Roorkee, Uttarakhand.
Read More